Free Newsletter
Sanofi reps await layoff news today
Sanofi-Aventis sales reps are sitting by the telephone this morning, waiting to find out whether they still have jobs. BNet Pharma quotes sources saying that laid-off reps will get the news today, apparently as part of a "realignment of sales and marketing resources" CEO Chris Viehbacher mentioned in his Q3 earnings presentation.
There's no word yet on how many reps are destined for the unemployment lines. But we do know that this round of layoffs follows a 10 percent cut in the Sanofi sales force last year. The company currently has some 5,600 or so reps.
Of course it's not much of a comfort to the Sanofi-ites who'll get bad news today, but they have plenty of company out there in the job market. Pharma has been on something of a sales rep layoff spree over the last couple of years. With mega-blockbusters going off patent, their equally mega sales forces have been slashed. Plus, drugmakers are trying new sales approaches, such as online detailing that doctors can check out anytime day or night.
BNet's source says Sanofi reps will get three weeks' severance pay for each year of service, with a bonus for over-50 reps. Stay tuned; as the layoffs happen, we're sure to hear more.
- read the BNet post
Related Articles:
Sanofi union tells workers to strike
1,300 eligible for Sanofi's 'voluntary departures'
Sanofi to amp up generics push, cut R&D
Sales reps see scaled-back incentive pay
Pharma reps between rock and hard place
Comments
Thank you for posting this article about the Sanofi-Aventis layoff on November 30, 2009. The same thing occurred on December 1, 2008 I was unfortunately treated the same way as others laid off at that time. They preach corporate values yet treat their associates poorly. Please note they plan to continue doing this every six months until their national sales rep count is down to their magic company number. In the meantime, the sales force remaining moves forward with fear of the next layoff and how the company will blindly lead them into being cut. But doing this annually at the Thanksgiving Holiday is both unprofessional and cold-hearted. Please do not post my name or email address with this comment. Thank you.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





